Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis
Azadeh Reyahi, Marie Studahl, Morten K. Skouboe, Stefanie Fruhwürth, Ryo Narita, Fanghui Ren, Moa Bjerhem Viklund, Marie B. Iversen, Mette Christiansen, Alexandra Svensson, Trine H. Mogensen, Kristina Eriksson, Søren R. Paludan
Azadeh Reyahi, Marie Studahl, Morten K. Skouboe, Stefanie Fruhwürth, Ryo Narita, Fanghui Ren, Moa Bjerhem Viklund, Marie B. Iversen, Mette Christiansen, Alexandra Svensson, Trine H. Mogensen, Kristina Eriksson, Søren R. Paludan
View: Text | PDF
Research Article Immunology Infectious disease

An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis

  • Text
  • PDF
Abstract

The mechanisms underlying susceptibility to recurrent herpes simplex virus type 2 (HSV-2) meningitis remain incompletely understood. In a patient experiencing multiple episodes of HSV-2 meningitis, we identified a monoallelic variant in the IKBKE gene, which encodes the IKKε kinase involved in induction of antiviral IFN genes. Patient cells displayed impaired induction of IFN-β1 (IFNB1) expression upon infection with HSV-2 or stimulation with double-stranded DNA (dsDNA) and failed to induce phosphorylation of STING, an activation marker of the DNA-sensing cyclic GMP-AMP synthase/stimulator of IFN genes (cGAS/STING) pathway. The patient allele encoded a truncated IKKε protein with loss of kinase activity and also capable of exerting dominant-negative activity. In stem cell–derived microglia, HSV-2–induced expression of IFNB1 was dependent on cGAS, TANK binding kinase 1 (TBK1), and IKBKE, but not TLR3, and supernatants from HSV-2–treated microglia exerted IKBKE-dependent type I IFN–mediated antiviral activity upon neurons. Reintroducing wild-type IKBKE into patient cells rescued IFNB1 induction following treatment with HSV-2 or dsDNA and restored antiviral activity. Collectively, we identify IKKε to be important for protection against HSV-2 meningitis and suggest a nonredundant role for the cGAS/STING pathway in human antiviral immunity.

Authors

Azadeh Reyahi, Marie Studahl, Morten K. Skouboe, Stefanie Fruhwürth, Ryo Narita, Fanghui Ren, Moa Bjerhem Viklund, Marie B. Iversen, Mette Christiansen, Alexandra Svensson, Trine H. Mogensen, Kristina Eriksson, Søren R. Paludan

×

Figure 4

The IKKε F105f*19 protein is unable to stimulate IFN induction.

Options: View larger image (or click on image) Download as PowerPoint
The IKKε F105f*19 protein is unable to stimulate IFN induction.
(A) HEK2...
(A) HEK293T cells were transiently transfected with IFN-β promoter firefly, β-actin promoter renilla reporter plasmids, and 100 ng of vector and plasmids encoding the full-length (WT) and truncated P1 F105fs*19 IKKε to measure IFN-β gene expression indicated by luciferase activity after 16 hours. (B) p-IRF3 (S396) and total IRF3 in whole-cell lysates from HEK293T cells expressing empty vector, WT, and P1 variant IKKε. IKKε (N/C-term epi), antibodies targeting epitopes in the N- and C-terminal parts of IKKε. (C) Lysates from HEK293T cells transfected with the indicated expression plasmids were immunoprecipitated with anti-FLAG and subjected to assays determining IKKε kinase activity. Data are presented as normalized levels of luciferase signals from the ATP measurements. (D and E) HEK293T cells were transfected with IFN-β promoter firefly, β-actin promoter renilla reporter plasmids, WT IKBKE, WT TBK1, and the indicated amounts of P1 IKBKE. (F) HEK293T cells were transfected with P1 IKBKE, and the indicated amounts of plasmids encoding FLAG-TBK1 and FLAG-IKKε. Cells were lysed 24 hours later and immunoblotted for p-TBK1 (S172), p-IKKε (S172), FLAG, IKKε (probing of only low molecular range of blotted membrane), and Vinculin. (G) HEK293T cells were transfected with 6x-His-WT or P1 IKBKE, FLAG-TBK1, and FLAG-IKBKE. Lysates were immunoprecipitated with anti-His and immunoblotted with anti-FLAG. (H–J) Control fibroblasts were transduced with lentiviral vectors encoding patient IKKε variant F105fs*19 (MOI: 12), infected with HSV-2 at the indicated MOI for 6 hours (H) or 24 hours (J), or transfected with dsDNA (I) for 6 hours. Data presented are from 1 representative of 6 (A, D, and E), 2 (F and G), and 3 (B, C, and H–J) independently performed experiments. Nonparametric Mann-Whitney rank-sum test was used for statistical analysis. Error bars represent SEM. **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001. NU = (Lucmax – Lucmeasured)/Lucmax (see Methods).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts